HELION BIOTECH ApS: Financial statements 2012
CVR: 31758106
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 34,037 and a net result of DKK 23,574. Equity in the 2012 report amounted to DKK 192,436. The solvency ratio was 88%.
- Gross Profit
- DKK 34,037
- Profit/Loss
- DKK 23,574
- Equity
- DKK 192,436
- Total Assets
- DKK 218,670
Official annual report
Keep an eye on HELION BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of January 1, 2012, ATHOS STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of HELION BIOTECH ApS.
As of January 1, 2012, Ankjær-Jensen & Partnere I/S, Statsautoriserede Revisorer has stepped down as auditor of HELION BIOTECH ApS.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.